About Norman Schwartz
Norman Schwartz is a director at Syncromune.
Norman Schwartz first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Norman Schwartz in the role, so the role may have started earlier or lasted longer.
Syncromune, Inc.
Director
2022 – 2026 · Fort Lauderdale, FL
Develops investigational immune therapies for people with metastatic solid tumors.
Key Colleagues at Startups
The people Norman Schwartz works with at each company, as listed on that company's latest Form D.
Syncromune, Inc. · Form D/A, May 11, 2026
JG
Joseph Gerardi
Executive officer
Jeffrey Cleland
Director
Douglas Watson
Lead Independent Director
JM
Joseph Maroon
Director
Stephen Dale
Chief Medical Officer
Charles Link
Executive Chairman & Chief Innovation Officer
Eamonn Hobbs
President & Chief Executive Officer, director
Kerri-Ann Millar
Chief Financial Officer
Agustin Gago
Chief Operating Officer